Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness–adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension

SUMMARY: In postmenopausal women with osteoporosis, up to 10 years of denosumab treatment significantly and continuously improved bone microarchitecture assessed by tissue thickness–adjusted trabecular bone score, independently of bone mineral density. Long-term denosumab treatment decreased the num...

Descripción completa

Detalles Bibliográficos
Autores principales: Hans, Didier, McDermott, Michele, Huang, Shuang, Kim, Min, Shevroja, Enisa, McClung, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202981/
https://www.ncbi.nlm.nih.gov/pubmed/36862192
http://dx.doi.org/10.1007/s00198-023-06708-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202981/
https://www.ncbi.nlm.nih.gov/pubmed/36862192
http://dx.doi.org/10.1007/s00198-023-06708-8

Ejemplares similares